IMPLANT AND PROSTHESIS FASTENER MARKET ANALYSIS

Market News

Global Implant & Prosthesis Fastener Market- Key Developments

In November 2022, Zimmer Biomet, a global medical technology company, announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for Persona OsseoTi Keel Tibia for cementless knee replacement. Persona OsseoTi is the latest addition to the clinically proven Persona Knee System and features a new porous version of Persona anatomic tibia with Zimmer Biomet's OsseoTi Porous Metal Technology, which uses anatomical data in combination with 3D printing technology to build a structure that directly mimics the architecture of human cancellous – or spongey – bone. This material is combined with a keeled design to deliver stable initial and biological fixation.

In July 2022, Acumed LLC., a medical device manufacturer company, announced the acquisition of ExsoMed, a medical device company providing orthopedic surgeons with innovative solutions in hand surgery. The addition of ExsoMed, whose products support an intramedullary approach to treating hand fractures, enhances Acumed's comprehensive portfolio of upper extremity solutions for simple to complex injuries.

In October 2022, the University of Utah Bionic Engineering Lab developed "Utah Bionic Leg," the most advanced bionic leg ever created. The university has forged a new partnership with the global company in the prosthetics industry, Ottobock, to license the technology behind Utah Bionic Leg and bring it to individuals with lower-limb amputations.

In December 2020, the U.S. Food and Drug Administration approved Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System, the first implant system marketed in the U.S. for adults who have transfemoral—or above-the-knee—amputations and who have or are anticipated to have rehabilitation problems with, or cannot use, a conventional socket prosthesis.